Definium tees up regulatory submission for psychedelic on Phase III hat trick
Definium Therapeutics plans to submit an NDA for DT120 in GAD In the first half of 2027.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo